1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 0000-0002-4697-6602 Daly, N.L. Dekan, Z. Jin, A.H. Alewood, P.F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking GE Angew. Chem. Int. Ed. Engl. ACIEAY 0179 1521-3773 56 14973 14976 10.1002/anie.201708927 28984021 Conotoxin phi-MiXXVIIA from the Superfamily G2 Employs a Novel Cysteine Framework that Mimics Granulin and Displays Anti-Apoptotic Activity. 2017 0000-0001-8891-1463 0000-0002-6841-4176 0000-0001-6937-0112 0000-0002-2945-1484 10.2210/pdb6ppc/pdb pdb_00006ppc 3422.695 Conopeptide phi-MiXXVIIA 1 syn polymer Conopeptide Mi045 no no EDCGSDCMPCGGECCCEPNSCIDGTCHHESSPN EDCGSDCMPCGGECCCEPNSCIDGTCHHESSPN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n pdbx_audit_support pdbx_nmr_spectrometer database_2 pdbx_database_status repository Initial release Author supporting evidence Data collection Database references Other 1 0 2019-08-14 1 1 2020-01-01 1 2 2023-06-14 _pdbx_audit_support.funding_organization _pdbx_nmr_spectrometer.model _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data Australia Australian Research Council (ARC) FT110100226 Solution structure of conotoxin MiXXVIIA N RCSB Y RCSB 2019-07-06 REL REL REL REL 69564 Soldier cone Conus miles sample 1 33 target function 50 15 isotropic 1 2D DQF-COSY isotropic 1 2D 1H-1H TOCSY isotropic 1 2D 1H-15N HSQC isotropic 1 2D 1H-13C HSQC isotropic 1 2D 1H-1H NOESY isotropic 1 2D 1H-1H TOCSY isotropic 1 2D 1H-1H NOESY 1 mM natural abundance 1 mM natural abundance 0% salt Not defined 1 5 pH ambient 290 K simulated annealing 1 lowest energy 1 mM phi-MiXXVIIA, 90% H2O/10% D2O 1 90% H2O/10% D2O solution 1 mM phi-MiXXVIIA, 100% D2O 2 100% D2O solution Bruker Biospin collection TopSpin CCPN data analysis CcpNmr Analysis Guntert, Mumenthaler and Wuthrich refinement CYANA Guntert, Mumenthaler and Wuthrich structure calculation CYANA 600 Bruker AVANCE GLU 1 n 1 GLU 1 A ASP 2 n 2 ASP 2 A CYS 3 n 3 CYS 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A ASP 6 n 6 ASP 6 A CYS 7 n 7 CYS 7 A MET 8 n 8 MET 8 A PRO 9 n 9 PRO 9 A CYS 10 n 10 CYS 10 A GLY 11 n 11 GLY 11 A GLY 12 n 12 GLY 12 A GLU 13 n 13 GLU 13 A CYS 14 n 14 CYS 14 A CYS 15 n 15 CYS 15 A CYS 16 n 16 CYS 16 A GLU 17 n 17 GLU 17 A PRO 18 n 18 PRO 18 A ASN 19 n 19 ASN 19 A SER 20 n 20 SER 20 A CYS 21 n 21 CYS 21 A ILE 22 n 22 ILE 22 A ASP 23 n 23 ASP 23 A GLY 24 n 24 GLY 24 A THR 25 n 25 THR 25 A CYS 26 n 26 CYS 26 A HIS 27 n 27 HIS 27 A HIS 28 n 28 HIS 28 A GLU 29 n 29 GLU 29 A SER 30 n 30 SER 30 A SER 31 n 31 SER 31 A PRO 32 n 32 PRO 32 A ASN 33 n 33 ASN 33 A author_defined_assembly 1 monomeric none 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N MET 8 A N MET 8 A O CYS 15 A O CYS 15 A N SER 20 A N SER 20 A O HIS 27 A O HIS 27 1 A CYS 3 -96.99 -67.72 1 A SER 5 -62.11 95.21 1 A GLU 13 -120.44 -169.72 1 A ASN 19 -52.81 173.35 2 A SER 5 -62.02 95.23 2 A GLU 13 -120.79 -169.76 2 A ASN 19 -52.61 172.92 3 A CYS 3 -100.12 -64.47 3 A SER 5 -62.34 94.90 3 A GLU 13 -126.65 -169.88 3 A ASN 19 -52.27 172.23 4 A SER 5 -62.33 94.99 4 A GLU 13 -121.27 -169.76 4 A ASN 19 -52.73 173.26 5 A CYS 3 -91.38 -63.90 5 A SER 5 -62.21 95.25 5 A GLU 13 -120.36 -169.71 5 A ASN 19 -53.00 173.70 6 A SER 5 -62.02 95.11 6 A GLU 13 -119.82 -169.75 6 A ASN 19 -52.81 173.54 6 A PRO 32 -69.78 98.67 7 A SER 5 -62.15 95.02 7 A GLU 13 -118.79 -169.59 7 A ASN 19 -52.78 173.40 7 A SER 30 -101.03 -74.32 8 A SER 5 -62.24 95.05 8 A GLU 13 -124.21 -169.92 8 A ASN 19 -52.21 172.21 8 A PRO 32 -69.77 86.44 9 A SER 5 -62.09 95.26 9 A GLU 13 -121.05 -169.56 9 A ASN 19 -52.41 172.63 10 A CYS 3 -103.27 -66.48 10 A SER 5 -62.37 94.95 10 A GLU 13 -127.97 -169.87 10 A ASN 19 -52.18 172.16 11 A CYS 3 -97.36 -64.14 11 A SER 5 -62.37 94.95 11 A ASN 19 -52.13 172.17 11 A SER 31 -151.58 70.17 12 A SER 5 -62.43 94.68 12 A ASN 19 -52.17 172.20 12 A SER 31 54.07 73.11 13 A CYS 3 -100.33 -64.13 13 A SER 5 -62.31 95.05 13 A ASN 19 -52.21 172.46 13 A SER 30 -115.50 51.89 14 A SER 5 -62.45 94.64 14 A GLU 13 -118.59 -169.57 14 A ASN 19 -52.47 172.22 15 A CYS 3 -104.49 -68.07 15 A SER 5 -61.88 94.95 15 A GLU 13 -117.78 -169.62 15 A ASN 19 -52.25 172.00 15 A SER 31 63.04 160.60 N Solution structure of conotoxin MiXXVIIA 1 N N disulf 1.999 A CYS 3 A SG CYS 3 1_555 A CYS 14 A SG CYS 14 1_555 disulf 2.103 A CYS 7 A SG CYS 7 1_555 A CYS 16 A SG CYS 16 1_555 disulf 2.023 A CYS 10 A SG CYS 10 1_555 A CYS 21 A SG CYS 21 1_555 disulf 1.932 A CYS 15 A SG CYS 15 1_555 A CYS 26 A SG CYS 26 1_555 TOXIN TOXIN A GLU 17 A GLU 17 1 A PRO 18 A PRO 18 -0.02 A GLU 17 A GLU 17 2 A PRO 18 A PRO 18 0.02 A GLU 17 A GLU 17 3 A PRO 18 A PRO 18 -0.01 A GLU 17 A GLU 17 4 A PRO 18 A PRO 18 0.01 A GLU 17 A GLU 17 5 A PRO 18 A PRO 18 -0.04 A GLU 17 A GLU 17 6 A PRO 18 A PRO 18 0.04 A GLU 17 A GLU 17 7 A PRO 18 A PRO 18 0.00 A GLU 17 A GLU 17 8 A PRO 18 A PRO 18 0.08 A GLU 17 A GLU 17 9 A PRO 18 A PRO 18 0.08 A GLU 17 A GLU 17 10 A PRO 18 A PRO 18 0.04 A GLU 17 A GLU 17 11 A PRO 18 A PRO 18 0.06 A GLU 17 A GLU 17 12 A PRO 18 A PRO 18 0.01 A GLU 17 A GLU 17 13 A PRO 18 A PRO 18 -0.03 A GLU 17 A GLU 17 14 A PRO 18 A PRO 18 -0.04 A GLU 17 A GLU 17 15 A PRO 18 A PRO 18 0.03 CG2RA_CONMI UNP 1 36 A0A0E3SVE7 EDCGSDCMPCGGECCCEPNSCIDGTCHHESSPN 36 68 6PPC 1 33 A0A0E3SVE7 A 1 1 33 2 2 anti-parallel anti-parallel A MET 8 A MET 8 A PRO 9 A PRO 9 A CYS 14 A CYS 14 A CYS 15 A CYS 15 A SER 20 A SER 20 A ILE 22 A ILE 22 A THR 25 A THR 25 A HIS 27 A HIS 27